Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Green Inflections: A Manual for Inside Plants - 2Vote In favor of Your Favored Sort Of Bevarage
- 3Vote In favor of Your Favored Distributed computing Administration
- 4Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships
- 5They died 'doing what they loved': The stories of workers in their 80s who died on the job
- From Amateur to Master: My Involvement in Photography
- A Manual for Well known Western television Series
- Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals
- Dick Van Dyke shares his secrets to longevity as he turns 100
- Manual for Tracking down Spending plan Agreeable Travel Objections
- Nature's Treats: 10 Organic products That Lift Prosperity
- Manual for Tracking down the Nearby Business sectors and Marketplaces
- Why doing good also makes us feel good, during the holidays and beyond
- Step by step instructions to Prepare with Senior Protection for Inward feeling of harmony.
